Corcept Therapeutics is trading at $86.45 (-4.44%) as of July 15, 2026, amid intraday volatility with no company-specific news to explain the move.
- The decline follows a period of significant price swings, including a 5.32% gain on July 14 and a 6.51% decline on July 13.
- No specific catalysts, such as earnings updates, FDA actions, or analyst moves, were identified for today's session.
- The stock's downward movement occurs while broader U.S. markets are trading slightly higher.